Literature DB >> 22661746

Young-onset amyotrophic lateral sclerosis: historical and other observations.

Martin R Turner1, Jessica Barnwell, Ammar Al-Chalabi, Andrew Eisen.   

Abstract

There is a wide range of age at initial symptom onset in amyotrophic lateral sclerosis despite a mean age of 65 years in population-based studies. 'Young-onset' amyotrophic lateral sclerosis typically refers to patients younger than ∼45 years and accounts for about 10% of cases in contemporary series. A review of published cases of amyotrophic lateral sclerosis from 1850 to 1950 revealed a far higher proportion of cases with young onset (>50%), with a steady decline to the contemporary figure. It is possible that this is not solely explained by increases in life expectancy. While there is still a rich variation in phenotypes among cases of young-onset amyotrophic lateral sclerosis, bulbar onset was found to be significantly under-represented in analysis of a large patient database, with implications for age-related vulnerabilities pertaining to focality of symptom onset. The timing of initiating pathological processes in relation to the emergence of symptoms is discussed, including the potential role of very early development and the interaction of epigenetic and environmental factors.

Entities:  

Mesh:

Year:  2012        PMID: 22661746     DOI: 10.1093/brain/aws144

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

1.  Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis.

Authors:  Pilar M Ferraro; Corrado Cabona; Giuseppe Meo; Claudia Rolla-Bigliani; Lucio Castellan; Matteo Pardini; Matilde Inglese; Claudia Caponnetto; Luca Roccatagliata
Journal:  Neuroradiology       Date:  2021-03-04       Impact factor: 2.804

2.  Genome-wide analysis of the heritability of amyotrophic lateral sclerosis.

Authors:  Margaux F Keller; Luigi Ferrucci; Andrew B Singleton; Pentti J Tienari; Hannu Laaksovirta; Gabriella Restagno; Adriano Chiò; Bryan J Traynor; Michael A Nalls
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

Review 3.  Gene discovery in amyotrophic lateral sclerosis: implications for clinical management.

Authors:  Ammar Al-Chalabi; Leonard H van den Berg; Jan Veldink
Journal:  Nat Rev Neurol       Date:  2016-12-16       Impact factor: 42.937

4.  Iron quantitative analysis of motor combined with bulbar region in M1 cortex may improve diagnosis performance in ALS.

Authors:  Yifang Bao; Yan Chen; Sirong Piao; Bin Hu; Liqin Yang; Haiqing Li; Daoying Geng; Yuxin Li
Journal:  Eur Radiol       Date:  2022-08-11       Impact factor: 7.034

5.  Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population.

Authors:  Mohamed Kazamel; Gary Cutter; Gwendolyn Claussen; Mohammad Alsharabati; Shin J Oh; Liang Lu; Peter H King
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-03-05       Impact factor: 4.092

Review 6.  Motor neuron disease: biomarker development for an expanding cerebral syndrome.

Authors:  Martin R Turner
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

Review 7.  Controversies and priorities in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Orla Hardiman; Michael Benatar; Benjamin R Brooks; Adriano Chio; Mamede de Carvalho; Paul G Ince; Cindy Lin; Robert G Miller; Hiroshi Mitsumoto; Garth Nicholson; John Ravits; Pamela J Shaw; Michael Swash; Kevin Talbot; Bryan J Traynor; Leonard H Van den Berg; Jan H Veldink; Steve Vucic; Matthew C Kiernan
Journal:  Lancet Neurol       Date:  2013-03       Impact factor: 44.182

Review 8.  Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis.

Authors:  Maria Elena Cicardi; Lara Marrone; Mimoun Azzouz; Davide Trotti
Journal:  EMBO J       Date:  2021-03-31       Impact factor: 11.598

9.  Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.

Authors:  Qian-Qian Wei; Yanbing Hou; Yongping Chen; Ruwei Ou; Bei Cao; Lingyu Zhang; Tianmi Yang; Huifang Shang
Journal:  Health Qual Life Outcomes       Date:  2021-07-20       Impact factor: 3.186

Review 10.  Mimics and chameleons in motor neurone disease.

Authors:  Martin R Turner; Kevin Talbot
Journal:  Pract Neurol       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.